mechanism of glp 1 GLP-1: Actions on Beta-cell Mass and Function Mechanisms of GLP-1 Receptor Agonist-Induced

20 , e1012033 (2024)

Doctors may prescribe it for people with a BMI of 30 or higher, or BMI of 27 with at least one weight-related condition such as high blood pressure, high cholesterol, or sleep apnea

After scrapping a Biden-era plan to cover obesity drugs in early 2025, the Trump administration reversed course: it struck deals with Novo Nordisk and Eli Lilly in November 2025 to cut GLP-1 prices, and a voluntary Medicare demonstration begins July 1, 2026 that lets participating drug plans cover GLP-1s for weight loss with a $50 monthly copay

This may be due to a number (or combination) of factors e.g

In many cases, injections are administered into the fatty tissue of the abdomen, thigh, or upper arm, as directed

This indicates a higher likelihood of meaningful improvement in desire and associated distress